WDR43 and glioma: Our findings revealed that compared with the normal controls, WDR43 expression exhibited a significant increase within tumors, including COAD, GBM, STAD, ESCA, pancreatic adenocarcinoma (PAAD), lower grade glioma (LGG), diffuse large B-cell lymphoma (DLBC), thymoma, LUSC, and READ (Fig. 1C, P < .05).